BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3291940)

  • 1. A single-blind randomised trial comparing adrenaline 1.0% with dipivalyl epinephrine (propine) 0.1% in the treatment of open-angle glaucoma and ocular hypertension.
    Mills KB; Jacobs NA
    Br J Ophthalmol; 1988 Jun; 72(6):465-8. PubMed ID: 3291940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects.
    Cebon L; West RH; Gillies WE
    Aust J Ophthalmol; 1983 Aug; 11(3):159-61. PubMed ID: 6639507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
    Shao H; Sun XY; Bai FG
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):104-7. PubMed ID: 8001439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drop attack in glaucoma. The Melbourne experience with topical miotics, adrenergic and neuronal blocking drops.
    West RH; Cebon L; Gillies WE
    Aust J Ophthalmol; 1983 Aug; 11(3):149-53. PubMed ID: 6639505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timolol and dipivalyl epinephrine combination therapy.
    McGuinness R; Frumar KD
    Aust J Ophthalmol; 1982 Aug; 10(3):179-82. PubMed ID: 7181758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
    Garzia R
    J Am Optom Assoc; 1982 Sep; 53(9):727-30. PubMed ID: 7130613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
    Ober M; Scharrer A
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
    Ober M; Scharrer A; Dausch D
    Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies conducted with a new epinephrine derivative for the treatment of glaucoma (Dipivalyl epinephrine)].
    Bischoff P
    Klin Monbl Augenheilkd; 1978 Apr; 172(4):565-8. PubMed ID: 349251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical comparison of dipivalyl epinephrine and epinephrine in the treatment of glaucoma.
    Kohn AN; Moss AP; Hargett NA; Ritch R; Smith H; Podos SM
    Am J Ophthalmol; 1979 Feb; 87(2):196-201. PubMed ID: 373450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular conjunctivitis on Dipivefrin therapy for glaucoma.
    Coleiro JA; Sigurdsson H; Lockyer JA
    Eye (Lond); 1988; 2 ( Pt 4)():440-2. PubMed ID: 3253137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Outlier" intraocular pressure readings: valid or invalid for statistical analysis?
    Dandona L; Morrison JC; Robin AL; Quigley HA
    Ophthalmic Surg; 1989 Oct; 20(10):737-43; discussion 744. PubMed ID: 2694044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two blind randomized cross-over trials in the treatment of primary open angle glaucoma.
    Mills KB; Hercules B; English M
    Trans Ophthalmol Soc U K (1962); 1981; 101 (Pt 4)():397-402. PubMed ID: 6764321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of epinephrine and dipivalyl epinephrine applied topically to the eye in patients with glaucoma.
    Kerr CR; Hass I; Drance SM; Walters MB; Schulzer M
    Br J Ophthalmol; 1982 Feb; 66(2):109-14. PubMed ID: 7037047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose combined guanethedine 1% and adrenaline 0.5% in the treatment of chronic simple glaucoma: a prospective study.
    Murray A; Glover D; Hitchings R
    Br J Ophthalmol; 1981 Aug; 65(8):533-5. PubMed ID: 7028082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
    Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study.
    O'Connor MA; Mooney DJ
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 6)():588-92. PubMed ID: 6385355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pressure reducing effects of pilocarpin in combination with Dipivalyl-epinephrine in glaucoma simplex (author's transl)].
    Krieglstein GK; Leydhecker W
    Klin Monbl Augenheilkd; 1979 Jul; 175(1):86-90. PubMed ID: 491472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.